Odyssey Therapeutics, Inc.
NASDAQ:ODTXBiotechnology
-$0.01 today
- Market cap
- $912.33M
- Beta
- 0.00
Volume 0.37M
Average 0.43M
ODTX EPS (Basic)
Net income attributable to common shareholders divided by the weighted average basic shares outstanding.
EPS (Basic) history
Currency unavailable · from the income statement
No EPS (Basic) data reported for this period type.
EPS (Basic) vs competitors
How ODTX compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Jun 2026 | $1.22 USD | +46.8% | — | |
| LTM Mar 2026 | -$0.56 USD | +59.7% | — | |
| LTM Mar 2026 | -$0.85 USD | +82.7% | — | |
AGMBAgomAb Therapeutics N.V. American Depositary Shares | FY2024 | -€1.26 EUR | -306.5% | — |
ORKAOruka Therapeutics, Inc. | LTM Sep 2026 | -$2.41 USD | +27.2% | — |
| LTM Sep 2026 | -$2.74 USD | -166.0% | — | |
ALMSAlumis Inc. Common Stock | LTM Jun 2026 | -$3.8 USD | +15.7% | — |
| LTM Mar 2026 | -$5.98 USD | +39.0% | — | |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — |
| Peer median (excluding ODTX) | — | +33.1% | — | |
Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Odyssey Therapeutics, Inc.
NASDAQ:ODTX
Intrinsic Alpha fair value
Locked
Current Price
$18.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.